Ultra-rapid nanoplasmonic colorimetry in microfluidics for antimicrobial susceptibility testing directly from specimens

  05 February 2026

Researchers developed QolorPhAST, a modular, automated antimicrobial susceptibility testing (AST) platform that uses nanoplasmonic colorimetry and microfluidics to rapidly identify bacteria and determine their antibiotic resistance. The system delivers results within minutes rather than days, eliminating the need for overnight cultures and pathogen isolation, and achieving an eightfold increase in detection speed compared with conventional AST.

QolorPhAST was validated across 10 bacterial species and 34 strains, accurately identifying pathogens and their minimal inhibitory concentrations in a multiplexed setup. In a proof-of-concept clinical study on blinded urinary tract infection samples, it achieved 100% species identification accuracy, with 91.8% categorical and 86.4% essential agreement, and a total turnaround time of 36 minutes. The findings indicate that QolorPhAST is a fast, accurate, user-friendly, and cost-effective approach with strong potential to significantly improve antibiotic decision-making and reduce the burden of antimicrobial resistance.

Further reading: Nature Nanotechnology
Author(s): Mahsa Jalali et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!